![]() | Only 14 pages are availabe for public view |
Abstract Hepatitis C virus (HCV) infection is a major health problem worldwide. Egypt is the country with the highest HCV infection epidemic in the world. Although chronic HCV infections are often clinically silent for decades, an estimated 85% of individuals infected with HCV develop persistent infection, and these patients are likely to end up with cirrhosis and liver cancer Cell-mediated immunity is thought to play a critical role in viral clearance and disease pathogenesis during HCV infection. Interleukin (IL)-12 is a cytokine that has been shown to have a potent role as an antiviral cytokine. The gene encoding IL-12 p40 is polymorphic and a functional single nucleotide polymorphism (SNP) of the 3-untranslated region rs3212227 at position 1188 A/C was associated with apparent resistance to HCV. The aim of this work was to study the association of IL-12 B gene polymorphism with various stages of liver disease in HCV infected patients. One hundred and fifty persons were included in the study; these persons were divided into five groups: group (I): Included 30 chronic hepatitis C virus (HCV) patients. group (II): Included 30 HCV patients with compensated cirrhosis. group (III): Included 30 HCV patients with decompensated cirrhosis. group (IV): Included 30 HCV patients complicated with HCC. |